Cerapedics
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Colorado, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
11025 Dover St Unit 1600, Westminster, C...Phone Number
(303) 974-6275Website
www.cerapedics.comRevenue
$49 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
3
1
1
1
1
About Cerapedics
Cerapedics is a global orthopedics company focused on enhancing bone repair through innovative products like PearlMatrix and i-FACTOR, which utilize P-15 Osteogenic Cell Binding Peptide technology. Their offerings include bone graft substitutes designed for spine, trauma, and orthopedic procedures, ensuring faster healing and improved patient outcomes. The company targets healthcare professionals and institutions, providing resources and evidence to support their products. Cerapedics is committed to advancing orthopedic care and improving the quality of life for patients worldwide.Explore more
Cerapedics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cerapedics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Cerapedics
Cerapedics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Cerapedics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Cerapedics has new funding data
Product Launch: Get notified when Cerapedics launches new products
Check out if Cerapedics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Cerapedics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Cerapedics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Cerapedics as Masked Content
Find more new buyers
Compare Similar Companies to Cerapedics
Compare insights from companies similar to Cerapedics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cerapedics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cerapedics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cerapedics.
Cerapedics financials insights
Gather financial insights about Cerapedics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2009
Series B
$15M
2012
Series C
$19M
2014
Debt
$9M
2015
Private Equity
$4M
Series A
$16.5M
2016
Series D
$11M
2017
Debt
$20M
2018
Private Equity
$22M
Cerapedics Tech Stack
A closer look at the technologies used by Cerapedics
See more technologies
Most Recent Scoops
Open Position
Open Position
Hiring Plans
Cerapedics has more open roles in Sales than it has had at any time in the past 12 months.
Hiring Plans
Open Position
Open Position
Cerapedics News & Media
Cerapedics' PearlMatrix P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator, Now Approved for Expanded Indications for Use
PearlMatrix is now the only Class III drug-device spinal bone graft approved for all major lumbar interbody surgical approaches in addition to expanded approved cage materials. Now even more patients can benefit from PearlMatrix, the first and only drug-device spinal bone graft proven to...Cerapedics Announces Publication in Spine of 24-Month ASPIRE Study Results of PearlMatrix™ P-15 Peptide Enhanced Bone Graft
ASPIRE pivotal IDE study results demonstrated PearlMatrix achieved superior clinical success and superior time-to-fusion at 24 months compared to local autograft. The rigor of the ASPIRE study reflects unmatched clinical design and results including: - More than twice as many patients...Cerapedics Announces First U.S. Patient Treated with PearlMatrix™ P-15 Peptide Enhanced Bone Graft following FDA approval
AdventHealth Avista, an Orthopedic and Spine Center of Excellence, conducted the first lumbar fusion procedure with PearlMatrix Bone Graft, the first and only bone growth accelerator for lumbar fusion. WESTMINSTER, Colo., July 8, 2025 /PRNewswire/ -- Cerapedics Inc., a global,...Cerapedics Announces FDA Approval of PearlMatrix™ P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator for Lumbar Fusion
ASPIRE pivotal Level-1 PMA IDE study evaluated PearlMatrix vs. local autograft in single-level TLIF procedures: - Demonstrated statistically superior fusion speed; - Achieved over twice as many patients fused at six months; - Included ~60% high-risk patients WESTMINSTER, Colo., June 23,...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cerapedics
Sign Up For FreeTo access detailed company insights
Cerapedics is a global orthopedics company focused on enhancing bone repair through innovative products like PearlMatrix and i-FACTOR, which utilize P-15 Osteogenic Cell Binding Peptide technology. Their offerings include bone graft substitutes designed for spine, trauma, and orthopedic procedures, ensuring faster healing and improved patient outco... Read More
